Cognitive assessments for the early diagnosis of dementia after stroke

Neuropsychiatric Disease and Treatment

Volumn 10, Issue , 2014, Pages 1743-1751

  Al Qazzaz, Noor Kamal ^a,b   Ali, Sawal Hamid ^a   Ahmad, Siti Anom ^c   Islam, Shabiul ^d  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b UNIVERSITY OF BAGHDAD   (Iraq)

^c UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^d INSTITUTE OF MICROENGINEERING AND NANOELECTRONICS IMEN   (Malaysia)

Author keywords

Early dementia detection; Neuropsychological assessments; Poststroke dementia; Vascular dementia

Indexed keywords

ATAXIC APHASIA; ATTENTION; CEREBROVASCULAR ACCIDENT; COGNITION; COGNITIVE DEFECT; CORTICAL SENSORY APHASIA; DEMENTIA; DISEASE ASSOCIATION; EARLY DIAGNOSIS; EXECUTIVE FUNCTION; HUMAN; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGICAL TEST; POSTSTROKE DEMENTIA; RECALL; RECOGNITION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SURVIVOR; VERBAL MEMORY; VISUAL MEMORY;

EID: 84907198364     PISSN: None     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S68443     Document Type: Review

References (51)

1. Cumming TB, Marshall RS, Lazar RM. Stroke, cognitive deficits, and rehabilitation: still an incomplete picture. Int J Stroke. 2013;8(1): 38–45.
2. Snaphaan L, de Leeuw FE. Poststroke memory function in nondemented patients: a systematic review on frequency and neuroimaging correlates. Stroke. 2007;38(1):198–203.
3. Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol. 2001;58(3): 397–405.
4. Tatemichi TK, Foulkes MA, Mohr JP, et al. Dementia in stroke survivors in the Stroke Data Bank cohort. Prevalence, incidence, risk factors, and computed tomographic fndings. Stroke. 1990;21(6):858–866.
5. Leys D, Hénon H, Mackowiak-Cordoliani MA, Pasquier F. Poststroke dementia. Lancet Neurol. 2005;4(11):752–759.
6. Firbank MJ, Burton EJ, Barber R, et al. Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivors. Neurobiol Aging. 2007;28(11):1664–1669.
7. McVeigh C, Passmore P. Vascular dementia: prevention and treatment. Clin Interv Aging. 2006;1(3):229–235.
8. Ankolekar S, Geeganage C, Anderton P, Hogg C, Bath PM. Clinical trials for preventing post stroke cognitive impairment. J Neurol Sci. 2010;299(1–2):168–174.
9. Cumming TB, Marshall RS, Lazar RM. Stroke, cognitive deficits, and rehabilitation: still an incomplete picture. Int J Stroke. 2013;8(1):38–45.
10. Erkinjuntti T, Gauthier S. The concept of vascular cognitive impairment. Front Neurol Neurosci. 2009;24:79–85.
11. Iemolo F, Duro G, Rizzo C, Castiglia L, Hachinski V, Caruso C. Pathophysiology of vascular dementia. Immun Ageing. 2009;6:13.
12. Jacova C, Kertesz A, Blair M, Fisk JD, Feldman HH. Neuropsychologi-cal testing and assessment for dementia. Alzheimers Dement. 2007;3(4): 299–317.
13. Desmond D W. Vascular dementia. Clin Neurosci Res. 2004;3(6): 437–448.
14. Korczyn AD, Vakhapova V, Grinberg LT. Vascular dementia. J Neurol Sci. 2012;322(1–2):2–10.
15. O’Brien JT, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment. Lancet Neurol. 2003;2(2):89–98.
16. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment– beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256(3):240–246.
17. Dauwels J, Vialatte F, Latchoumane C, Jeong J, Cichocki A. EEG synchrony analysis for early diagnosis of Alzheimer’s disease: a study with several synchrony measures and EEG data sets. Conf Proc IEEE Eng Med Biol Soc. 2009:2224–2227.
18. Ruitenberg A, Ott A, van Swieten JC, Hofman A, Breteler MM. Incidence of dementia: does gender make a difference? Neurobiol Aging. 2001;22(4):575–580.
19. Snaphaan L, Rijpkema M, van Uden I, Fernández G, de Leeuw FE. Reduced medial temporal lobe functionality in stroke patients: a functional magnetic resonance imaging study. Brain. 2009;132(Pt 7):1882–1888.
20. Planton M, Peiffer S, Albucher JF, et al. Neuropsychological outcome after a first symptomatic ischaemic stroke with ‘good recovery’. Eur J Neurol. 2012;19(2):212–219.
21. Werring DJ, Gregoire SM, Cipolotti L. Cerebral microbleeds and vascular cognitive impairment. J Neurol Sci. 2010;299(1–2):131–135.
22. Sheng B, Cheng LF, Law CB, Li HL, Yeung KM, Lau KK. Coexisting cerebral infarction in Alzheimer’s disease is associated with fast dementia progression: applying the National Institute for Neurological Disorders and Stroke/Association Internationale pour la Recherche et l’Enseignement en Neurosciences Neuroimaging Criteria in Alzheimer’s Disease with Concomitant Cerebral Infarction. J Am Geriatr Soc. 2007;55(6):918–922.
23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association. 1994.
24. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):89–98.
25. Smith T, Gildeh N, Holmes C. The Montreal Cognitive Assessment: validity and utility in a memory clinic setting. Can J Psychiatry. 2007; 52(5):329–332.
26. Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges JR. A brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementia. Neurology. 2000;55(11):1613–1620.
27. Cedazo-Minguez A, Winblad B. Biomarkers for Alzheimer’s disease and other forms of dementia: clinical needs, limitations and future aspects. Exp Gerontol. 2010;45(1):5–14.
28. Hampel H, Frank R, Broich K, et al. Biomarkers for Alzheimer’s disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov. 2010;9(7):560–574.
29. Bagnoli S, Failli Y, Piaceri I, et al. Suitability of neuropsychological tests in patients with vascular dementia (VaD). J Neurol Sci. 2012; 322(1–2):41–45.
30. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140: 566–572.
31. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982–1983;17(1):37–49.
32. Gorelick PB. Risk factors for vascular dementia and Alzheimer disease. Stroke. 2004;35(11 suppl 1):2620–2622.
33. Tham W, Auchus AP, Thong M, et al. Progression of cognitive impairment after stroke: one year results from a longitudinal study of Singaporean stroke patients. J Neurol Sci. 2002;203–204:49–52.
34. Mok VC, Wong A, Lam WW, Baum LW, Ng HK, Wong L. A case-controlled study of cognitive progression in Chinese lacunar stroke patients. Clin Neurol Neurosurg. 2008;110(7):649–656.
35. Khedr EM, Hamed SA, El-Shereef HK, et al. Cognitive impairment after cerebrovascular stroke: relationship to vascular risk factors. Neu-ropsychiatr Dis Treat. 2009;5:103–116.
36. Kandiah N, Wiryasaputra L, Narasimhalu K, et al. Frontal subcortical ischemia is crucial for post stroke cognitive impairment. J Neurol Sci. 2011;309(1–2):92–95.
37. Jaillard A, Naegele B, Trabucco-Miguel S, LeBas JF, Hommel M. Hidden dysfunctioning in subacute stroke. Stroke. 2009;40(7): 2473–2479.
38. Auchus AP, Chen CP, Sodagar SN, Thong M, Sng EC. Single stroke dementia: insights from 12 cases in Singapore. J Neurol Sci. 2002; 203–204:85–89.
39. Stebbins GT, Nyenhuis DL, Wang C, et al. Gray matter atrophy in patients with ischemic stroke with cognitive impairment. Stroke. 2008; 39(3):785–793.
40. Sachdev PS, Brodaty H, Valenzuela MJ, Lorentz LM, Koschera A. Progression of cognitive impairment in stroke patients. Neurology. 2004;63(9):1618–1623.
41. Graham NL, Emery T, Hodges JR. Distinctive cognitive profiles in Alzheimer’s disease and subcortical vascular dementia. J Neurol Neu-rosurg Psychiatry. 2004;75(1):61–71.
42. Garrett KD, Browndyke JN, Whelihan W, et al. The neuropsychological profile of vascular cognitive impairment – no dementia: comparisons to patients at risk for cerebrovascular disease and vascular dementia. Arch Clin Neuropsychol. 2004;19(6):745–757.
43. Mok VC, Wong A, Lam WW, et al. Cognitive impairment and functional outcome after stroke associated with small vessel disease. J Neurol Neurosurg Psychiatry. 2004;75(4):560–566.
44. Bour A, Rasquin S, Boreas A, Limburg M, Verhey F. How predictive is the MMSE for cognitive performance after stroke? J Neurol. 2010; 257(4):630–637.
45. Cao M, Ferrari M, Patella R, Marra C, Rasura M. Neuropsychological findings in young-adult stroke patients. Arch Clin Neuropsychol. 2007; 22(2):133–142.
46. Yoshida H, Terada S, Honda H, et al. Validation of Addenbrooke’s cognitive examination for detecting early dementia in a Japanese population. Psychiatry Res. 2011;185(1–2):211–214.
47. Raimondi C, Gleichgerrcht E, Richly P, et al. The Spanish version of the Addenbrooke’s Cognitive Examination – Revised (ACE-R) in subcortical ischemic vascular dementia. J Neurol Sci. 2012;322(1–2): 228–231.
48. Dong Y, Sharma VK, Chan BP, et al. The Montreal Cognitive Assessment (MoCA) is superior to the Mini-Mental State Examination (MMSE) for the detection of vascular cognitive impairment after acute stroke. J Neurol Sci. 2010;299(1–2):15–18.
49. Sikaroodi H, Yadegari S, Miri SR. Cognitive impairments in patients with cerebrovascular risk factors: a comparison of Mini Mental Status Exam and Montreal Cognitive Assessment. Clin Neurol Neurosurg. 2013;115(8):1276–1280.
50. Pendlebury ST, Mariz J, Bull L, Mehta Z, Rothwell PM. MoCA, ACE-R, and MMSE versus the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Neuropsychological Battery after TIA and stroke. Stroke. 2012;43(2):464–469.
51. Atluri VS, Pilakka-Kanthikeel S, Samikkannu T, et al. Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder. Mol Brain. 2014;7:37.